CSL LIMITED (CSL)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:

CSL - CSL LIMITED
FNArena Sector :
Pharmaceuticals & Biotech/Lifesciences
Year End: June
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Index: ASX20 | ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS
FNArena Sector : Pharmaceuticals & Biotech/Lifesciences
Year End: June
CSL is a global biotechnology company that researches, develops, manufactures and markets products for the treatment of human diseases. With a market cap of over $138bn it is one of Australia's top three largest index weights. The former Commonwealth Serum Laboratory listed in June 1994 and has generated an average annual return of 28% since (up until mid-2020). CSL is the world's largest collector of plasma and the second largest producer of vaccines.
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$277.25
16 May |
OPEN $279.87 |
HIGH $279.99 |
550,739 LOW $276.27 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 0% |
OTHER COMPANIES IN THE SAME SECTOR | |||
CUV . ACR . AHZ . IDT . IVX . MSB . MYX . RNO . OSL . TFC . TIS . KZA . AGH . FTT . PAR . ADO . PYC . RAC . RCE . ZNO . AVH . LGP . SPL . ARX . AFP . 1AD . TLX . PNV . MVP . BNO . NXS . GSS . EOF . NEU . PAL . PBP . BOT . IMU . MDC . IMM . PXS . HXL . MXC . OPT . ANP . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY22 Forecast |
FY23 Forecast |
---|---|---|
EPS (cps) | 670.3 | xxx |
DPS (cps) | 289.4 | xxx |
EPS Growth | N/A | xxx |
DPS Growth | N/A | xxx |
PE Ratio | 40.9 | xxx |
Dividend Yield | 1.1% | xxx |
Div Pay Ratio(%) | 43.2% | xxx |
All estimates have been converted into AUD by FNArena at present FX values.
Last ex-div: 07/03 - ex-div 145.92c (franking 0%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | 700.0 |
DPS All | xxx | xxx | xxx | xxx | xxx | 293.9 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 13,761.5 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 2,452.9 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 4,855.5 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 23.14 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | 30.84 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | 17.61 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | 13.65 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | 30.84 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 22.31 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | 1,967.4 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
This is work in progress. Bear with us. It'll be amazing.
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
CSL STOCK CHART

FNArena News on CSL
1 |
Rudy’s View: Trend Is Turning For Corporate ProfitsMay 12 2022 - Rudi's View |
2 |
Rudi’s View: Ampol, CSL, Temple & Webster And WiseTech GlobalApr 28 2022 - Rudi's View |
3 |
CSL: Buy Trigger AheadApr 26 2022 - Technicals |
4 |
Rudi’s View: Peter’s Portfolio ReviewedApr 13 2022 - Rudi's View |
5 |
Rudi’s View: Real Market Support Is InvisibleApr 07 2022 - Rudi's View |
Latest Pharmaceuticals & Biotech/Lifesciences News
1 |
CSL: Buy Trigger AheadApr 26 2022 - Technicals |
2 |
Why CSL Fell Sharply YesterdayDec 17 2021 - Australia |
3 |
Beating The Biotech BluesSep 14 2021 - International |
4 |
Uncertainty Prevails For CSLAug 19 2021 - Australia |
5 |
Flying High – Medicinal Marijuana In AustraliaJul 26 2021 - Australia |
6 |
Wesfarmers On Drugs?Jul 13 2021 - Australia |
7 |
Is CSL’s Plasma Recovery Now Priced In?Jun 23 2021 - Australia |
8 |
CSL: Buy The DipJun 22 2021 - Technicals |
9 |
CSL To Retest Its High?May 25 2021 - Technicals |
10 |
Treasure Chest: CSL Plasma At Turning Point?May 05 2021 - Treasure Chest |